Moderna's CMV trial offers further upside - UBS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/29/2026

1. SPY
2. MDB
3. MTN
4. AIR
5. FFAI
6. AMD
7. ORCL
8. SPCX
9. NVDA
10. SMMT

Go back to Moderna's CMV trial offers further upside - UBS
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 198.16 +0.88 (0.45%)
Previous Close $197.28    52 Week High $0.52 
Open $197.78    52 Week Low $0.08 
Day High $208.90    P/E N/A 
Day Low $195.67    EPS $-3.80 
Volume 6,330,741